Welcome to LookChem.com Sign In|Join Free

CAS

  • or

505-66-8

Post Buying Request

505-66-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

505-66-8 Usage

Important pharmaceutical intermediates

Homopiperazine is a nitrogen-containing seven-membered ring hetero-atomic compound and is an important pharmaceutical intermediate. The majority of its derivatives has strong biological activity and medicinal value and can be used for synthesizing homopiperazine hydrochloride, cyclizine, carbamazepine, chlorcyclizine and other drugs. Western medicine often takes homopiperazine as raw material for the modified quinoline and isoquinoline derivatives, quinolone derivative, thiazolidine carboxylic acid amide derivatives and other drugs, and for the synthesis of pyridazine, nitroxyl-containing benzylamine derivatives, water-soluble azole and other drugs which has good efficacy for the treatment of cardiovascular disease, interstitial plasma cell pneumonia especially for AIDS patients with Pneumocystis pneumonia, asthma, central nervous system disorders including depression and anxiety disorders. For example, 1-(5-isoquinoline-sulfonyl) homopiperazine hydrochloride is effective in the treatment of symptoms such as chronic angina disease, vitiligo, depression, anxiety, cerebral vasospasm and cerebral vasospasm caused cerebral ischemia and other symptoms. Homopiperazine and its high-piperazine derivatives have become important pharmaceutical intermediates and have exhibited great potential of being sedative, anti-psychotic, anti-inflammatory and anti-neurotic and is an important product of a connecting link between the proceeding and the following in the chemical industry and pharmaceutical industry and have been widely applied to the pharmaceuticals, pesticides, surfactants, energetic materials and other fields. Currently the domestic heterocyclic compounds are mainly used for producing the quinolone antibacterial drugs. This drug, through inhibiting the bacterial DNA gyrase, blocks the DNA replication and produces the antimicrobial effects. According to the report of ARMIGER H et al, after using homopiperazine as substitute of piperazine for the synthesis of drugs like cyclizine, homo-chlorcyclizine and other drugs, animal experiments had demonstrated that the activity of antihistamine drugs had been significantly enhanced. Its main products include quinoline and isoquinoline derivatives, quinolone derivative, thiazolidine carboxylic acid amide derivatives and other drugs, as well as the synthesis of disubstituted pyridazine, the nitroxyl-containing benzyl amine derivatives and water-soluble azole drug. The derivative of homopiperazine molecule with the hydrogen atom in the amino group being substituted by long-chain alkyl or alkoxy can be used as wetting agents, emulsifying agents, detergents, coloring agents; homopiperazine and its derivatives, because of containing staining keratin filament, can be used as oxidation coloring agents and have vibrant colors and high solidness properties. It plays an important role in the dyeing, especially in the dyeing of human hair. Polymers containing homopiperazine monomer have many unique properties such as being able to improve the melting point and improve their solubility. Resin and synthetic fiber containing such a polymer have been applied to a variety of special fields. The above information is edited by the lookchem of Dai Xiongfeng.

Preparation

Homopiperazine can be synthesized using amino compounds such as N-(2-cyanoethyl)-ethylenediamine, N-(β-hydroxy)-1,3-propanediamine, ethylenediamine as raw material so that homopiperazine has various kinds of synthetic routes according to different raw materials. With the development of China's petrochemical industry, for the synthesis of the starting raw material of homopiperazine, alcohols and ethylene diamine, it not only has low price but also can get high-quality product as well as extremely abundant source. Currently, though there are homopiperazine domestic manufacturers, but the technology is lagged behind, the quality is not high and the production output is limited, all the above points are in urgent need for being transformed and improved. From this perspective, it is imperative for accelerating the process of development of fine chemical products of homopiperazine with a wide range of application. Therefore, the market prospect of the homopiperazine is very broad. Using ethylenediamine as the raw material: the method uses the easily available ethylenediamine as the initial raw material, further goes through sulfonylation, cyclization, de-sulfonylation, 3-step reaction for synthesizing homopiperazine with the total yield being 78%. Within this synthetic method, during the first step of ethylenediamine sulfonylation, the addition of a phase transfer catalyst can significantly improve the product yield with the yield being 86%. During the second step of cyclization reaction, selection of NaH/ DMF reaction system can enable the completion of the cyclization reaction under milder reaction conditions. Finally, under HBr/HAc/PhOH reaction conditions, remove the sulfonyl group with a yield being 91% to give the final product homopiperazine. The results indicate that it is an excellent homopiperazine synthesis route of various kinds of advantages including easily available raw materials, simple operation and high yield with certain prospects for industrial application.

Uses

Different sources of media describe the Uses of 505-66-8 differently. You can refer to the following data:
1. It can be used as organic and pharmaceutical synthesis intermediates, for example, being applied to the synthesis of fasudil hydrochloride. Homopiperazine acts as a corrosion inhibitor for iron. It has also been used in the preparation of potent H3 receptor antagonists for use as treatments for neurodegenerative conditions such as Alzheimer disease.
2. pharmaceutical intermediate
3. Homopiperazine is used to prepare 1,4-bis-(2-thiazolyl)-1,4-diazacycloheptane by reacting with 2-bromo-thiazole. It acts as an intermediate for repaglinide and fasudil hydrochloride. It is also used in the preparation of potent H3 receptor antagonists, which is used for the treatment of neurodegenerative conditions. Further, it is used in vesicant, cosmetic, emulsifier and energetic material. It acts as a corrosion inhibitor for iron. In pharmaceuticals, it is employed as antipyretic and reducing blood sugar, adiposity, calm, antipsychotic and anti-nervous.

Chemical Properties

white to light yellow crystalline mass

Check Digit Verification of cas no

The CAS Registry Mumber 505-66-8 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,0 and 5 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 505-66:
(5*5)+(4*0)+(3*5)+(2*6)+(1*6)=58
58 % 10 = 8
So 505-66-8 is a valid CAS Registry Number.
InChI:InChI=1/C5H12N2/c1-2-6-4-5-7-3-1/h6-7H,1-5H2/p+2

505-66-8 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A15751)  Homopiperazine, 98%   

  • 505-66-8

  • 25g

  • 414.0CNY

  • Detail
  • Alfa Aesar

  • (A15751)  Homopiperazine, 98%   

  • 505-66-8

  • 100g

  • 1155.0CNY

  • Detail
  • Alfa Aesar

  • (A15751)  Homopiperazine, 98%   

  • 505-66-8

  • 500g

  • 4561.0CNY

  • Detail
  • Aldrich

  • (H16604)  Homopiperazine  98%

  • 505-66-8

  • H16604-25G

  • 519.48CNY

  • Detail
  • Aldrich

  • (H16604)  Homopiperazine  98%

  • 505-66-8

  • H16604-100G

  • 1,206.27CNY

  • Detail

505-66-8Synthetic route

C15H28N2O4

C15H28N2O4

1,4-Diazacycloheptane
505-66-8

1,4-Diazacycloheptane

Conditions
ConditionsYield
With sodium hydroxide In ethanol for 3h; Reflux;87%
C5H10Br2N2

C5H10Br2N2

1,4-Diazacycloheptane
505-66-8

1,4-Diazacycloheptane

Conditions
ConditionsYield
With sodium hydroxide In toluene Autoclave; Reflux; Large scale;85%
1,4-bistrifluoroacetyl homopiperazine

1,4-bistrifluoroacetyl homopiperazine

1,4-Diazacycloheptane
505-66-8

1,4-Diazacycloheptane

Conditions
ConditionsYield
Stage #1: 1,4-bistrifluoroacetyl homopiperazine With hydrogenchloride In ethanol at 40℃; for 5h; Autoclave; Large scale;
Stage #2: With sodium hydroxide In water; toluene at 20℃; for 1h; Autoclave; Large scale;
83.05%
2-[(3-aminopropyl)amino]ethanol
4461-39-6

2-[(3-aminopropyl)amino]ethanol

1,4-Diazacycloheptane
505-66-8

1,4-Diazacycloheptane

Conditions
ConditionsYield
With hydrogen bromide
With 1,4-dioxane; hydrogen; nickel at 200℃; under 14710.2 Torr;
N,N'-Di(phenylsulphonyl)hexahydro-1,4-diazepin
5451-44-5

N,N'-Di(phenylsulphonyl)hexahydro-1,4-diazepin

1,4-Diazacycloheptane
505-66-8

1,4-Diazacycloheptane

Conditions
ConditionsYield
With sulfuric acid
ethylene glycol
107-21-1

ethylene glycol

Trimethylenediamine
109-76-2

Trimethylenediamine

1,4-Diazacycloheptane
505-66-8

1,4-Diazacycloheptane

Conditions
ConditionsYield
With 1,4-dioxane; hydrogen; nickel at 200℃; under 29420.3 Torr;
1,4-Diazacycloheptane
505-66-8

1,4-Diazacycloheptane

2-fluoropyridine
372-48-5

2-fluoropyridine

1,4-bis-(2-pyridyl)-1,4-diazacycloheptane
131119-29-4

1,4-bis-(2-pyridyl)-1,4-diazacycloheptane

Conditions
ConditionsYield
With triethylamine; Polytetrafluoroethylene In tetrahydrofuran at 100℃; under 6000480 Torr; for 96h;100%
With triethylamine In tetrahydrofuran at 100℃; under 6000480 Torr; for 96h;100%
1,4-Diazacycloheptane
505-66-8

1,4-Diazacycloheptane

benzoyl chloride
98-88-4

benzoyl chloride

2-Methoxybenzoyl chloride
21615-34-9

2-Methoxybenzoyl chloride

(4-benzoyl-[1,4]diazepan-1-yl)-(2-methoxy-phenyl)-methanone

(4-benzoyl-[1,4]diazepan-1-yl)-(2-methoxy-phenyl)-methanone

Conditions
ConditionsYield
Stage #1: 1,4-Diazacycloheptane With n-butyllithium In tetrahydrofuran at 20℃; for 1h; Metallation;
Stage #2: benzoyl chloride In tetrahydrofuran Acylation;
Stage #3: 2-Methoxybenzoyl chloride In tetrahydrofuran Acylation;
100%
1,4-Diazacycloheptane
505-66-8

1,4-Diazacycloheptane

5-(2,6-dimethoxyphenyl)penta-(2E,4E)-dienoic acid

5-(2,6-dimethoxyphenyl)penta-(2E,4E)-dienoic acid

1,4-bis[5-(2,6-dimethoxyphenyl)penta-(2E,4E)-dienoyl]hexahydro-1,4-diazepine

1,4-bis[5-(2,6-dimethoxyphenyl)penta-(2E,4E)-dienoyl]hexahydro-1,4-diazepine

Conditions
ConditionsYield
100%
1,4-Diazacycloheptane
505-66-8

1,4-Diazacycloheptane

(E,E)-5-(3,4,5-trimethoxyphenyl)-2,4-pentadienoic acid
28010-23-3

(E,E)-5-(3,4,5-trimethoxyphenyl)-2,4-pentadienoic acid

1,4-bis[5-(3,4,5-trimethoxyphenyl)penta-(2E,4E)-dienoyl]hexahydro-1,4-diazepine

1,4-bis[5-(3,4,5-trimethoxyphenyl)penta-(2E,4E)-dienoyl]hexahydro-1,4-diazepine

Conditions
ConditionsYield
100%
1,4-Diazacycloheptane
505-66-8

1,4-Diazacycloheptane

N-(tert-butyloxycarbonyl)-O-(phenylmethyl)-L-tyrosine 4-nitrophenol ester
13512-59-9

N-(tert-butyloxycarbonyl)-O-(phenylmethyl)-L-tyrosine 4-nitrophenol ester

N-(tert-butyloxycarbonyl)-O-(phenylmethyl)-L-tyrosine, 1-homopiperazine amide
636607-88-0

N-(tert-butyloxycarbonyl)-O-(phenylmethyl)-L-tyrosine, 1-homopiperazine amide

Conditions
ConditionsYield
In dichloromethane at 20℃; for 2h;100%
1,4-Diazacycloheptane
505-66-8

1,4-Diazacycloheptane

ethyl 2-chloro-5-oxo-5H-benzo[4,5]thiazolo[3,2-a][1,8]naphthyridine-6-carboxylate
881633-93-8

ethyl 2-chloro-5-oxo-5H-benzo[4,5]thiazolo[3,2-a][1,8]naphthyridine-6-carboxylate

ethyl 2-(1,4-diazepan-1-yl)-5-oxo-5H-benzo[4,5]thiazolo[3,2-a][1,8]naphthyridine-6-carboxylate

ethyl 2-(1,4-diazepan-1-yl)-5-oxo-5H-benzo[4,5]thiazolo[3,2-a][1,8]naphthyridine-6-carboxylate

Conditions
ConditionsYield
In acetonitrile at 80℃; for 18h;100%
1,4-Diazacycloheptane
505-66-8

1,4-Diazacycloheptane

4,4-dimethyl-2-oxo-1,2,3,4-tetrahydroquinoline-6-sulfonyl chloride
1061596-54-0

4,4-dimethyl-2-oxo-1,2,3,4-tetrahydroquinoline-6-sulfonyl chloride

6-(1,4-diazepan-1-ylsulfonyl)-4,4-dimethyl-3,4-dihydroquinolin-2(1H)-one
1061596-63-1

6-(1,4-diazepan-1-ylsulfonyl)-4,4-dimethyl-3,4-dihydroquinolin-2(1H)-one

Conditions
ConditionsYield
In dichloromethane at 0 - 20℃;98%
1,4-Diazacycloheptane
505-66-8

1,4-Diazacycloheptane

formaldehyd
50-00-0

formaldehyd

2,4-di-tert-Butylphenol
96-76-4

2,4-di-tert-Butylphenol

N,N'-bis(2-hydroxy-3,5-di tertiarybutylbenzyl)homopiperazine
527672-96-4

N,N'-bis(2-hydroxy-3,5-di tertiarybutylbenzyl)homopiperazine

Conditions
ConditionsYield
In water for 24h; Mannich Aminomethylation; Inert atmosphere; Schlenk technique; Reflux;98%
Stage #1: 1,4-Diazacycloheptane; formaldehyd In methanol for 3h; Reflux;
Stage #2: 2,4-di-tert-Butylphenol In methanol for 12h; Reflux;
80%
In methanol; water for 24h; Mannich reaction; Reflux;24%
1,4-Diazacycloheptane
505-66-8

1,4-Diazacycloheptane

5-(5-Chlorosulphonyl-2-ethoxyphenyl)-1-methyl-3-n-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one
139756-22-2

5-(5-Chlorosulphonyl-2-ethoxyphenyl)-1-methyl-3-n-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one

5-(5-(1,4-diazepane-1-ylsulfonyl)-2-ethoxyphenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one
1352238-20-0

5-(5-(1,4-diazepane-1-ylsulfonyl)-2-ethoxyphenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one

Conditions
ConditionsYield
With triethylamine In ethanol at 0 - 10℃; for 1h; Concentration; Inert atmosphere;98%
1,4-Diazacycloheptane
505-66-8

1,4-Diazacycloheptane

16-(3,5,6-Trichloro-4-trifluoromethyl-pyridin-2-yl)-1,4,7,10,13-pentaoxa-16-aza-cyclooctadecane

16-(3,5,6-Trichloro-4-trifluoromethyl-pyridin-2-yl)-1,4,7,10,13-pentaoxa-16-aza-cyclooctadecane

C41H58Cl4F6N6O10

C41H58Cl4F6N6O10

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran at 100℃; under 6000480 Torr; for 96h;97%
1,4-Diazacycloheptane
505-66-8

1,4-Diazacycloheptane

1,4-Diformyl-homopiperazin

1,4-Diformyl-homopiperazin

Conditions
ConditionsYield
In acetonitrile for 8.5h; Formylation;97%
1,4-Diazacycloheptane
505-66-8

1,4-Diazacycloheptane

5-(2-methoxyphenyl)penta-(2E,4E)-dienoic acid

5-(2-methoxyphenyl)penta-(2E,4E)-dienoic acid

1,4-bis[5-(2-methoxyphenyl)penta-(2E,4E)-dienoyl]hexahydro-1,4-diazepine

1,4-bis[5-(2-methoxyphenyl)penta-(2E,4E)-dienoyl]hexahydro-1,4-diazepine

Conditions
ConditionsYield
97%
1,4-Diazacycloheptane
505-66-8

1,4-Diazacycloheptane

5-(pyridin-3-yl)-2,4-pentadieneoic acid
118420-15-8

5-(pyridin-3-yl)-2,4-pentadieneoic acid

1,4-bis[5-(3-pyridyl)penta-(2E,4E)-dienoyl]hexahydro-1,4-diazepine

1,4-bis[5-(3-pyridyl)penta-(2E,4E)-dienoyl]hexahydro-1,4-diazepine

Conditions
ConditionsYield
97%
1,4-Diazacycloheptane
505-66-8

1,4-Diazacycloheptane

3-(3,4-dihydro-6,7-dimethoxy-2-naphthyl)prop-(2E)-enoic acid

3-(3,4-dihydro-6,7-dimethoxy-2-naphthyl)prop-(2E)-enoic acid

1,4-bis[3-(3,4-dihydro-6,7-dimethoxy-2-naphthyl)prop-(2E)-enoyl]hexahydro-1,4-diazepine

1,4-bis[3-(3,4-dihydro-6,7-dimethoxy-2-naphthyl)prop-(2E)-enoyl]hexahydro-1,4-diazepine

Conditions
ConditionsYield
97%
1,4-Diazacycloheptane
505-66-8

1,4-Diazacycloheptane

2-bromo-pyridine
109-04-6

2-bromo-pyridine

1,4-bis-(2-pyridyl)-1,4-diazacycloheptane
131119-29-4

1,4-bis-(2-pyridyl)-1,4-diazacycloheptane

Conditions
ConditionsYield
With triethylamine; Polytetrafluoroethylene In tetrahydrofuran at 100℃; under 6000480 Torr; for 96h;96%
1,4-Diazacycloheptane
505-66-8

1,4-Diazacycloheptane

(E)-3-(3-quinolyl)-2-propenoic acid hydrochloride

(E)-3-(3-quinolyl)-2-propenoic acid hydrochloride

1,4-bis[3-(3-quinolyl)prop-(2E)-enoyl]hexahydro-1,4-diazepine

1,4-bis[3-(3-quinolyl)prop-(2E)-enoyl]hexahydro-1,4-diazepine

Conditions
ConditionsYield
96%
1,4-Diazacycloheptane
505-66-8

1,4-Diazacycloheptane

benzyl chloride
100-44-7

benzyl chloride

1,4-dibenzylhomopiperazine
21637-41-2

1,4-dibenzylhomopiperazine

Conditions
ConditionsYield
With sodium carbonate In ethanol for 20h; Heating;96%
1,4-Diazacycloheptane
505-66-8

1,4-Diazacycloheptane

2-nitrobenzyl chloride
612-23-7

2-nitrobenzyl chloride

2-((4-(2-nitrobenzyl)-1,4-diazepan-1-yl)methyl) benzenamine

2-((4-(2-nitrobenzyl)-1,4-diazepan-1-yl)methyl) benzenamine

Conditions
ConditionsYield
With potassium carbonate In acetonitrile for 48h; Reflux;95.8%
1,4-Diazacycloheptane
505-66-8

1,4-Diazacycloheptane

1-chloro-2-(3,4,5-trimethoxyphenyl)ethane
50987-66-1

1-chloro-2-(3,4,5-trimethoxyphenyl)ethane

1,4-bis<2-(3,4,5-trimethoxyphenyl)ethyl>perhydro-1,4-diazepine

1,4-bis<2-(3,4,5-trimethoxyphenyl)ethyl>perhydro-1,4-diazepine

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide; toluene for 14h; Heating;95%
1,4-Diazacycloheptane
505-66-8

1,4-Diazacycloheptane

16-(6-Chloro-3-nitro-pyridin-2-yl)-1,4,7,10,13-pentaoxa-16-aza-cyclooctadecane

16-(6-Chloro-3-nitro-pyridin-2-yl)-1,4,7,10,13-pentaoxa-16-aza-cyclooctadecane

C39H62N8O14

C39H62N8O14

Conditions
ConditionsYield
With triethylamine In tetrahydrofuran at 100℃; under 6000480 Torr; for 144h;95%
1,4-Diazacycloheptane
505-66-8

1,4-Diazacycloheptane

5-(3,5-dimethoxyphenyl)penta-(2E,4E)-dienoic acid
74333-64-5

5-(3,5-dimethoxyphenyl)penta-(2E,4E)-dienoic acid

1,4-bis[5-(3,5-dimethoxyphenyl)penta-(2E,4E)-dienoyl]hexahydro-1,4-diazepine

1,4-bis[5-(3,5-dimethoxyphenyl)penta-(2E,4E)-dienoyl]hexahydro-1,4-diazepine

Conditions
ConditionsYield
95%

505-66-8Relevant articles and documents

Antibacterial Activities of Transition Metal complexes of Mesocyclic Amidine 1,4-diazacycloheptane (DACH)

Rehman, Sadia,Ikram, Muhammad,Subhan, Fazle,Sinnokrot, Mutasem,Khan, Waliullah

, p. 936 - 942 (2019)

The titled compound 1,4-diazacycloheptane have vibrational freedom which allows it to coordinate to metal through 1st and 4th positions. Copper (II) and Nickel (II) complexes of DACH were prepared and characterized through UV-Visible, FT-IR, elemental analyses, conductance, and magnetic susceptibilities and compared to the results published in Inorg. Chem., 8(3), 528 (1969). The prepared complexes bearing different coordinating or non-coordinating anions were screened against four different pathogenic bacterial strains to study anionic effect on antibacterial activity. The MIC values of all the compounds suggest that [Cu(DACH)2Br2] is almost inactive against the tested microbes except Staph aureus. Rest of the metal complexes are active at their respective MIC values.

A cardiovascular drug fasudil hydrochloride intermediate simple synthesis of process

-

Paragraph 0021; 0022, (2019/05/15)

The invention discloses a cardiovascular drug fasudil hydrochloride intermediate simple synthesis process, taking ethylenediamine, BOC anhydride, DCM into the reaction bottle stirring, GC to intermediate state the reaction is complete, the reaction solution is concentrated under reduced pressure, concentrate, tetrahydrofuran to stir until completely dissolved, addition of sodium methoxide, thermal insulation stirring [...] 1, 3 - dibromo propane, thermal insulation to stir until the reaction is complete, the reaction solution is poured into ice water, extracted with ethyl acetate twice, combined with the organic phase, a washed, dried with anhydrous sodium sulfate, concentrated under reduced pressure to dry, taking concentrated intermediate, 40% sodium hydroxide, ethanol into the reaction bottle stirring, the reaction solution is heated to reflux, thermal insulation reaction to intermediate state hydrolysis, reverse the ice water, for two armor uncle ether extraction, the combined organic phase, a washed, dried with anhydrous sodium sulfate, concentrated under reduced pressure to dry, adding hexane stirring crystallization, to obtain the product, yield 87.0%, GC99%, raw materials of this invention is simple and easy, the product has high purity, simple and convenient operation, the work efficiency is high.

Method for preparing homopiperazine by utilizing ethyl trifluoroacetate

-

Paragraph 0067; 0078-0084; 0086; 0087, (2017/07/21)

The invention discloses a method for preparing homopiperazine by utilizing ethyl trifluoroacetate. The method comprises the following steps: (1) taking ethylenediamine as an initial raw material; enabling the ethylenediamine to react with the ethyl trifluoroacetate under the action of an organic solvent, so as to prepare bistrifluoroacetylethylenediamine; (2) enabling the bistrifluoroacetylethylenediamine obtained by the step (1) to react with a 1,3-disubstituted propane compound under the action of a solvent and a catalyst, so as to obtain bistrifluoroacetyl homopiperazine; (3) enabling the bistrifluoroacetyl homopiperazine obtained by the step (2) to react with a hydrogen chloride ethanol solution to obtain homopiperazine bihydrochloride; recycling the ethyl trifluoroacetate; (4) enabling the homopiperazine bihydrochloride obtained by the step (3) to react with alkali under the action of a solvent and a catalyst, so as to prepare the homopiperazine. The method disclosed by the invention has the beneficial effects of simplicity and convenience for operation, relatively low cost, relatively high yield, relatively small pollution and wide applicable range, and can meet the requirements on industrial production of products.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 505-66-8